Illumina’s plan will maximize shareholder value Illumina is engaged with regulators to define GRAIL’s path forward as expeditiously as possible Icahn’s director nominees do not add value to the Board and will damage Illumina’s core business SAN DIEGO — Illumina (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today issued the following response […]
Significant value unlocked for Enzo shareholders with continued focus on remaining businesses. FARMINGDALE, NY — Enzo Biochem, Inc. (NYSE:ENZ) announced today that it has entered into an agreement for Labcorp (NYSE: LH) to acquire the assets of Enzo’s Clinical Laboratory division (Enzo Clinical Labs). The transaction between two leading global life sciences companies follows several […]
INTEGRA Biosciences is delighted to announce that it has acquired Miroculus, a biotechnology specialist focused on developing hands-off automation solutions for next generation sequencing (NGS) protocols. This will allow INTEGRA to expand its product range for library preparation, offering significant time savings to academic, research and diagnostics laboratories using NGS and, ultimately, accelerating discovery in […]
Life sciences tools veteran brings decades of experience leading successful teams, commercializing industry-defining technology platforms, and scaling global organizations. MONHEIM AM RHEIN, Germany – Resolve Biosciences, a company pioneering Molecular Cartography™ technology, announced today that it has appointed John Stark as Chief Executive Officer. As part of this transition, Resolve Biosciences’ previous CEO, Jason Gammack, will […]
CARLSBAD, Calif. — Universal Sequencing Technology Corporation (UST), a global leader in genomic sequencing innovations, announced today the release of a high throughput microbial WGS library preparation kit enabling 2nd-generation short-read sequencers to produce long-range results in a much affordable price for microbial genomes. With this special high throughput kit, users can pool more microbial samples […]
Enhanced usability to support PCR applications in basic and translational research, process development, and quality control HERCULES, Calif. — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced the launch of its PTC Tempo 96 and PTC Tempo Deepwell Thermal Cyclers, designed to optimize PCR […]
SAN DIEGO — Bionano Laboratories today announced the expansion of its clinical testing menu with the launch of two new laboratory developed tests (LDTs) based on optical genome mapping (OGM), OGM-DxTM Postnatal Whole Genome SV and OGM-DxTM Prenatal Whole Genome SV. These LDTs offer a genome-wide assessment of structural variants (SVs) and provide comprehensive testing for most […]
Early customer data reinforces accuracy and flexibility of novel long-read technology, unlocking access to challenging, low DNA input samples SAN DIEGO — Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that its first product based on its novel Illumina Complete Long Read technology is now available to order. The […]
Paraphase Enables Researchers to Analyze Genes That are Critically Relevant but Hard to Genotype MENLO PARK, Calif. — PacBio (NASDAQ: PACB), a leading developer of highly accurate sequencing solutions, today announced a new informatics method that genotypes gene paralogs and pseudogenes with high accuracy. The new computational tool, named “Paraphase,” enables variant calling, copy number analysis and phasing […]
Collaboration provides a solution for a more in-depth analysis of cancer biomarkers BOSTON and LAUSANNE, Switzerland – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and the leader in data-driven medicine, is partnering with Agilent to offer a comprehensive solution for cancer analysis. Through the partnership, the SOPHiA DDM™ Platform will be integrated […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
